반응식
[CH3:1][C:2]1[CH:11]=[CH:10][C:9]2[C:4](=[CH:5][CH:6]=[CH:7][C:8]=2[N:12]2[CH2:17][CH2:16][N:15]([CH2:18][CH2:19][C:20]3[CH:25]=[CH:24][CH:23]=[C:22]([N+:26]([O-:28])=[O:27])[CH:21]=3)[CH2:14][CH2:13]2)[N:3]=1.[Cl:29]C1C=C2C(C=CC(C)=N2)=C(N2CCNCC2)C=1.[N+](C1C=CC(S(OCCC2C=CC=C([N+]([O-])=O)C=2)(=O)=O)=CC=1)([O-])=O>>[Cl:29][C:6]1[CH:5]=[C:4]2[C:9]([CH:10]=[CH:11][C:2]([CH3:1])=[N:3]2)=[C:8]([N:12]2[CH2:17][CH2:16][N:15]([CH2:18][CH2:19][C:20]3[CH:25]=[CH:24][CH:23]=[C:22]([N+:26]([O-:28])=[O:27])[CH:21]=3)[CH2:14][CH2:13]2)[CH:7]=1참가 물질
4
실험 절차
The title compound was prepared in 92% yield using a similar procedure to description D5 starting from 7-chloro-2-methyl-5-(1-piperazinyl)quinoline (D16) and 2-(3-Nitrophenyl)ethyl 4-nitrobenzenesulfonate (D15).
출처 및 근거
- ORD 기록
- ord-1a371ec5f0954aadba4ca9cc774c215b
- 출처 데이터셋
- uspto-grants-2010_06
- 특허 번호
- US07732600B2
연결된 노트
불러오는 중…